furosemide has been researched along with trimethoprim, sulfamethoxazole drug combination in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Johnson, KL; Kalish, RS; LaPorte, A; Wood, JA | 1 |
| Halevy, S; Livni, E | 1 |
| Asada, H; Miyagawa, F; Miyao, M; Nishikawa, M; Ogawa, K; Yamamoto, S | 1 |
4 other study(ies) available for furosemide and trimethoprim, sulfamethoxazole drug combination
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Sulfonamide-reactive lymphocytes detected at very low frequency in the peripheral blood of patients with drug-induced eruptions.
Topics: Adult; Aged; Cells, Cultured; Drug Eruptions; Female; Furosemide; Humans; Lymphocyte Activation; Male; Middle Aged; Sulfisoxazole; T-Lymphocytes; Trimethoprim, Sulfamethoxazole Drug Combination | 1994 |
The role of macrophage migration inhibition factor in toxic epidermal necrolysis.
Topics: Acetazolamide; Aged; Aged, 80 and over; Anti-Infective Agents; Anti-Infective Agents, Urinary; Diuretics; Furosemide; Humans; Macrophage Migration-Inhibitory Factors; Macrophages; Male; Middle Aged; Nitrofurantoin; Stevens-Johnson Syndrome; Trimethoprim, Sulfamethoxazole Drug Combination | 1997 |
Predisposition to multi-drug hypersensitivity after administration of mogamulizumab.
Topics: Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Diuretics; Drug Eruptions; Esomeprazole; Factor Xa Inhibitors; Fatal Outcome; Female; Furosemide; Humans; Immunologic Factors; Lenalidomide; Leukemia-Lymphoma, Adult T-Cell; Middle Aged; Proton Pump Inhibitors; Pyridines; Thiazoles; Trimethoprim, Sulfamethoxazole Drug Combination | 2018 |